Maria R. Gigante

Rome, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Comment on: Identification of clinical phenotypes and disease trajectories in SLE using AI through a natural language processing framework: reply.

Comment on: Identification of clinical phenotypes and disease trajectories in SLE using AI through a natural language processing framework: reply.

Journal: Rheumatology (Oxford, England)

Published: April 16, 2026

The ontogeny of myeloid-stromal synovial tissue niches in rheumatoid arthritis.

The ontogeny of myeloid-stromal synovial tissue niches in rheumatoid arthritis.

Journal: Research square

Published: December 03, 2025

The ontogeny of myeloid-stromal synovial tissue niches in rheumatoid arthritis.

The ontogeny of myeloid-stromal synovial tissue niches in rheumatoid arthritis.

Journal: bioRxiv : the preprint server for biology

Published: November 24, 2025

Identification of clinical phenotypes and disease trajectories in SLE using AI through a natural language processing framework.

Identification of clinical phenotypes and disease trajectories in SLE using AI through a natural language processing framework.

Journal: Rheumatology (Oxford, England)

Published: August 31, 2025

Location and amount of joint involvement differentiates rheumatoid arthritis into different clinical subsets.

Location and amount of joint involvement differentiates rheumatoid arthritis into different clinical subsets.

Journal: NPJ digital medicine

Published: March 18, 2025

Minimally invasive retrieval and characterisation of tenosynovial tissue in rheumatoid arthritis: a novel approach to study at-risk, active, and remission stages.

Minimally invasive retrieval and characterisation of tenosynovial tissue in rheumatoid arthritis: a novel approach to study at-risk, active, and remission stages.

Journal: Annals of the rheumatic diseases

Published: October 28, 2024

Synovial tissue myeloid dendritic cell subsets exhibit distinct tissue-niche localization and function in health and rheumatoid arthritis.

Synovial tissue myeloid dendritic cell subsets exhibit distinct tissue-niche localization and function in health and rheumatoid arthritis.

Journal: Immunity

Published: August 31, 2022

Correction: Peripheral blood CD4posCD25posFoxP3pos cells and inflammatory cytokines as biomarkers of response in rheumatoid arthritis patients treated with CTLA4-Ig.

Correction: Peripheral blood CD4posCD25posFoxP3pos cells and inflammatory cytokines as biomarkers of response in rheumatoid arthritis patients treated with CTLA4-Ig.

Journal: Arthritis research & therapy

Published: July 25, 2022

Peripheral blood CD4posCD25posFoxP3pos cells and inflammatory cytokines as biomarkers of response in rheumatoid arthritis patients treated with CTLA4-Ig.

Peripheral blood CD4posCD25posFoxP3pos cells and inflammatory cytokines as biomarkers of response in rheumatoid arthritis patients treated with CTLA4-Ig.

Journal: Arthritis research & therapy

Published: January 20, 2022

Inclusion of Synovial Tissue-Derived Characteristics in a Nomogram for the Prediction of Treatment Response in Treatment-Naive Rheumatoid Arthritis Patients.

Inclusion of Synovial Tissue-Derived Characteristics in a Nomogram for the Prediction of Treatment Response in Treatment-Naive Rheumatoid Arthritis Patients.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: June 17, 2020

Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies.

Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies.

Journal: Frontiers in medicine

Published: April 17, 2020

No higher risk of respiratory symptoms in Italian rheumatological patients under IL-6R-inhibitor therapy in SARS-CoV-2 pandemic.

No higher risk of respiratory symptoms in Italian rheumatological patients under IL-6R-inhibitor therapy in SARS-CoV-2 pandemic.

Journal: Rheumatology (Oxford, England)

Published: April 09, 2020

Showing 1-12 of 22

Last Updated: 09/26/2026